Moreover, the PHS treatment increased the transcription and activity of SphK, which was accompanied by prominent increases in the transcription levels of ROS‐detoxifying enzymes and PR proteins in the later phase of the pathogen infection. The gene discussed is TMEM37; the disease is infection.